Illumina to Seek FDA OK for MDx System This Year | GenomeWeb

SAN FRANCISCO (GenomeWeb News) – Illumina hopes to receive US Food and Drug Administration clearance of its BeadXpress system for molecular diagnostic applications in the second half of 2009, President and CEO Jay Flatley said today at the JPMorgan Healthcare Conference held here.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.